What is the isotretinoin (Accutane) dosage?

Capsule strengths and how they are taken
ProductCapsule strengthsDaily dose and lengthWith meals
Accutane10, 20, 30 and 40 mg soft gelatin10.5 to 1 mg/kg/day for 15 to 20 weeks1With food1
Absorica10, 20, 25, 30, 35 and 40 mg20.5 to 1 mg/kg/day for 15 to 20 weeks2With or without meals2
Absorica LD8, 16, 20, 24, 28 and 32 mg20.4 to 0.8 mg/kg/day for 15 to 20 weeks2With or without meals2
Claravis10, 20, 30 and 40 mg hard gelatin30.5 to 1 mg/kg/day for 15 to 20 weeks3With food3

The Accutane label gives 0.5 to 1 mg/kg/day in two divided doses with food for 15 to 20 weeks.1

Capsule strengths and how they are taken

The table is set at the top of the page

All three labels give these daily amounts in two divided doses.123 The Absorica label says Absorica and Absorica LD are not substitutable, even at the shared 20 mg strength.2 The Accutane label says to swallow the capsules whole with a full glass of liquid, and not to chew or suck them.1 It says failure to take Accutane with food will significantly decrease absorption.1

What the labels say about dose

The Accutane label says adults whose disease is very severe with scarring or trunk involvement may need adjustments up to 2 mg/kg/day, as tolerated.1 The Absorica label says adults with very severe disease (scarring, trunk involvement) may increase to 2 mg/kg/day of Absorica or 1.6 mg/kg/day of Absorica LD, in divided doses.2 The Accutane label says once-daily dosing is not recommended.1

For a 60 kg body weight the Accutane label's dosing table, based on taking it with food, lists 30 mg a day at 0.5 mg/kg, 60 mg at 1 mg/kg and 120 mg at 2 mg/kg, with a note to the 2 mg/kg column that the recommended dosage range is 0.5 to 1 mg/kg/day.1 The Accutane label adds that in studies comparing 0.1, 0.5 and 1 mg/kg/day all doses cleared disease initially, but lower doses needed retreatment more often.1

The Accutane label says a prescription can be dispensed as no more than a 30 day supply, and refills require a new prescription and a new authorization from the iPLEDGE system.1 The Claravis label says a fasting lipid profile and liver function tests are to be completed in all patients before Claravis use.3

Course length, cumulative dose and time between courses

The Accutane label says the drug may be stopped early if total nodule count falls by more than 70% before 15 to 20 weeks.1 It says that if a second course is needed, it is not to be started until at least 8 weeks after completion of the first course.1 A systematic review says traditional dosing guidelines recommending 0.5 to 1.0 mg/kg/day to reach a cumulative dose of 120 to 150 mg/kg were largely derived from early experience with severe nodulocystic acne.4 The three labels read do not state a cumulative dose.

What trials gave, arm by arm

Milligram has no logged isotretinoin dose or schedule to report.

TrialDose and schedulePeopleLength
Cascio Ingurgio, single-centre randomized single-blind trial, moderate-to-severe cystic acne5Cumulative 120 or 150 mg/kg; comparable lesion and severity change (all p > 0.20); 12-month relapse 26.7% and 32.3% (p = 0.619)5Number not given in the saved record512 months of follow-up after stopping5
Chingshubam, randomized single-blinded non-inferiority trial, grade 2 facial acne620 mg on alternate days against 30 mg daily for one week per month6Sixty adults6Four months6
Kothari 202170.5 mg/kg/day daily against 0.5 mg/kg on alternate days against 20 mg daily790 patients724 weeks7
Kaseem 202270.5–1 mg/kg daily against 0.25–0.4 mg/kg daily against 0.5–0.7 mg/kg daily for 1 week every 4 weeks7107 patients724 weeks7
Agarwal 201171 mg/kg/day; 1 mg/kg/day alternate day; 1 mg/kg/day for 1 week/weeks (pulse); 20 mg alternate day7120 patients74 months7

The Kothari 2021, Kaseem 2022 and Agarwal 2011 rows are as listed in a systematic review, not taken from the trial reports.7

What reviews conclude about lower doses

A review of 15 randomized trials says low-dose and intermittent regimens offered comparable efficacy to high-dose regimens with fewer mucocutaneous adverse effects.7 A systematic review, defining low dose as ≤0.5 mg/kg/day and conventional dose as 0.5–1.0 mg/kg/day, found comparable 24-week efficacy in trials conducted predominantly in moderate acne, with low certainty of evidence for efficacy.4

Storage

The Accutane and Claravis labels say to store at 20° to 25°C and protect from light.13 The Absorica label gives the same range, with excursions permitted between 15°C and 30°C.2 The labels read give only these room-temperature conditions, and no storage condition once a pack has been started.

Frequently asked questions

Is there a label for a short Accutane cycle?

The labels read give one course length, and no label for a short cycle or a cycle calculator was located.

Does an isotretinoin dose convert to a syringe volume?

No liquid or injectable form appears in the labels read, so capsules are not measured in mL and a U-100 syringe does not apply.

References

  1. DailyMed. Isotretinoin Capsules USP. 2026. dailymed.nlm.nih.gov
  2. DailyMed. These highlights do not include all the information needed to use ABSORICA/ABSORICA LD safely and effectively. See full prescribing information for ABSORICA/ABSORICA LD. ABSORICA ® (isotretinoin) capsules, for oral use ABSORICA LD ® (isotretinoin) capsules, for oral use Initial U.S. Approval: 1982. 2026. dailymed.nlm.nih.gov
  3. DailyMed. These highlights do not include all the information needed to use CLARAVIS safely and effectively. See full prescribing information for CLARAVIS. CLARAVIS™ (isotretinoin capsules), for oral use Initial U.S. Approval: 1982. 2026. dailymed.nlm.nih.gov
  4. Front Med. Individualizing isotretinoin dosing in acne: comparable 24-week efficacy and better tolerability at lower daily doses. 2026. pmc.ncbi.nlm.nih.gov
  5. PubMed. Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trial. 2026. pubmed.ncbi.nlm.nih.gov
  6. Indian J Med Res. Continuous alternate day vs intermittent daily fixed doses of oral isotretinoin in grade 2 acne vulgaris. 2026. pmc.ncbi.nlm.nih.gov
  7. Postepy Dermatol Alergol. Effectiveness and safety of different dosing regimens of isotretinoin for acne vulgaris: a systematic review. 2025. pmc.ncbi.nlm.nih.gov